Literature DB >> 3917816

Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.

J R Baker, P A Metcalf, I M Holdaway, R N Johnson.   

Abstract

Serum fructosamine activity was studied in 42 patients with type I (insulin dependent) diabetes mellitus and 30 non-diabetic volunteers as an index of blood glucose control. There was a significant correlation both between fructosamine and glycosylated haemoglobin values (r = 0.82) and between fructosamine and the fasting C peptide concentration (r = -0.81). Test results in 14 of the diabetics reflected the mean plasma glucose concentration calculated from 25 serial estimations in a single 24 hour period (r = 0.75; p less than 0.01) but not the mean amplitude of glycaemic excursion (r = 0.23; p greater than 0.05). Fructosamine concentrations measured in these multiple blood specimens did not change significantly throughout the day (mean coefficient of variation 4.1%) despite wide variability of the respective plasma glucose concentrations (mean coefficient of variation 36.2%). It is concluded that a single random serum sample analysed for fructosamine concentration provides a simple and reliable assessment of glucose homoeostasis in patients with type I diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917816      PMCID: PMC1417357          DOI: 10.1136/bmj.290.6465.352

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

2.  Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974).

Authors:  R B Passey; R L Gillum; J B Fuller; F M Urry; M L Giles
Journal:  Clin Chem       Date:  1977-01       Impact factor: 8.327

Review 3.  Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility.

Authors:  T K Mayer; Z R Freedman
Journal:  Clin Chim Acta       Date:  1983-01-24       Impact factor: 3.786

4.  A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United Kingdom.

Authors:  B J Boucher; J M Burrin; B J Gould; P N John; G Lewis; C Owens; R Paisey; C A Pennock; P Y Poon; I S Ross; S G Welch; J M White
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

5.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

Authors:  R N Johnson; P A Metcalf; J R Baker
Journal:  Clin Chim Acta       Date:  1983-01-07       Impact factor: 3.786

6.  A critical evaluation of methods of monitoring diabetic control.

Authors:  R Tattersall; S Walford; I Peacock; E Gale; S Allison
Journal:  Diabetes Care       Date:  1980 Jan-Feb       Impact factor: 19.112

7.  Patient self-monitoring of blood glucose and refinements of conventional insulin treatment.

Authors:  R Tattersall; E Gale
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

8.  Evidence for independent regulation of human erythrocyte and adipocyte insulin receptors.

Authors:  E A Benson; P Gales-Benson; R B Elliott; I M Holdaway
Journal:  Clin Endocrinol (Oxf)       Date:  1982-07-01       Impact factor: 3.478

9.  Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

Authors:  S Madsbad; T Krarup; P McNair; C Christiansen; O K Faber; I Transbøl; C Binder
Journal:  Acta Med Scand       Date:  1981

10.  Characteristics of glycemic stability.

Authors:  F J Service; R L Nelson
Journal:  Diabetes Care       Date:  1980 Jan-Feb       Impact factor: 19.112

View more
  17 in total

Review 1.  Glycated haemoglobin in the year 2000.

Authors:  E S Kilpatrick
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

2.  Fructosamine or glycated haemoglobin as a measure of diabetic control?

Authors:  J Allgrove; B L Cockrill
Journal:  Arch Dis Child       Date:  1988-04       Impact factor: 3.791

3.  Biofeedback-assisted relaxation in insulin-dependent diabetes: A replication and extension study.

Authors:  A McGrady; G Graham; B Bailey
Journal:  Ann Behav Med       Date:  1996-09

4.  Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism.

Authors:  Ayman M Mahmoud; Sanaa M Abd El-Twab; Eman S Abdel-Reheim
Journal:  Eur J Nutr       Date:  2016-04-08       Impact factor: 5.614

5.  Serum fructosamine levels in dairy cows related to metabolic status in early lactation.

Authors:  E Ropstad
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

6.  Glucose does not influence the insulin-like growth factor (JGF) binding to carrier proteins (IGFBPs): analysis of rat and human serum by western ligand blotting.

Authors:  S Cianfarani; V J Frost; M O Savage; J M Holly
Journal:  Experientia       Date:  1993-08-15

Review 7.  Impact of blood glucose monitoring on diabetic control: obstacles and interventions.

Authors:  T Wysocki
Journal:  J Behav Med       Date:  1989-04

8.  A telemedicine system that includes a personal assistant improves glycemic control in pump-treated patients with type 1 diabetes.

Authors:  Mercedes Rigla; M Elena Hernando; Enrique J Gómez; Eulalia Brugués; Gema García-Sáez; Verónica Torralba; Agustina Prados; Luisa Erdozain; Joana Vilaverde; Alberto de Leiva
Journal:  J Diabetes Sci Technol       Date:  2007-07

9.  Evaluation of the fructosamine test for the measurement of plasma protein glycation.

Authors:  R Flückiger; T Woodtli; W Berger
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

10.  Comparison of fructosamine and glycated haemoglobin in children with type 1 (insulin-dependent) diabetes mellitus.

Authors:  P Mullis; H Völkle; V Sigrist; K Zuppinger
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.